Skip to main content

Booth Bruce's Form 4 filing

Kymera Therapeutics, Inc. (KYMR) · filed Apr 24, 2026

Accession no.
0001451612-26-000006
Filed
Apr 24, 2026
Trade date
Apr 22, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $539.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Booth BruceCIK 0001451612Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 22, 2026Common StockMOption exerciseAcquired+5,641$14.18+$79,989.385,641Direct
Apr 22, 2026Common StockMOption exerciseAcquired+259$20.00+$5,1805,900Direct
Apr 22, 2026Common StockSSaleDisposed−5,900$89.96−$530,7640Direct
Apr 22, 2026Common StockSSaleDisposed−88$90.08−$7,927.043,899,829Indirect
Apr 22, 2026Common StockSSaleDisposed−12$90.08−$1,080.96674,944Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 22, 2026Common StockMOption exerciseDisposed−5,641$0.00$00Direct
Apr 22, 2026Common StockMOption exerciseDisposed−259$0.00$039,868Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)